Abstract
Background
Segmentectomy has been recommended for peripheral small-sized non-small cell lung cancer (NSCLC). This study aimed to evaluate whether three dimensionally (3D) guided cone-shaped segmentectomy can achieve long-term outcomes comparable with lobectomy for small-sized NSCLC in the middle third of the lung parenchyma.
Methods
This study retrospectively screened patients with small NSCLC (≤2 cm) who underwent segmentectomy or lobectomy between January 2012 and June 2019. Tumor location was determined by 3D multiplanar reconstruction. The cone-shaped segmentectomy was performed with the guidance of 3D computed tomographic bronchography and angiography. The log-rank test, Cox hazard proportional regression, and propensity score-matching analyses were adopted for prognostic evaluation.
Results
After screening, 278 patients with segmentectomy and 174 subjects undergoing lobectomy were selected. All the patients had R0 resection, and no 30- or 90-day mortality was observed. The median follow-up time was 47.3 months. The 5-year overall survival (OS) was 99.6 %, and the disease-free survival (DFS) was 97.5 % for the patients undergoing segmentectomy. After propensity score-matching, the patients with segmentectomy (n = 112) had an OS (P = 0.530) and a DFS (P = 0.390) similar to those of the patients who underwent lobectomy (n = 112). The multivariable Cox regression analysis indicated no significant survival differences between segmentectomy and lobectomy [DFS: hazard ratio, 0.56 (95 % confidence interval (CI) 0.16–1.97, P = 0.369); OS: HR, 0.35 (95 % CI 0.06–2.06, P = 0.245)] after adjustment for other factors. Further analysis showed that segmentectomy achieved comparable OS (P = 0.540) and DFS (P = 0.930) for NSCLC in the middle-third and peripheral lung parenchyma (n = 454).
Conclusions
For selected NSCLCs size 2 cm or smaller in the middle third of the lung field, 3D-guided cone-shaped segmentectomy was able to achieve long-term outcomes comparable with lobectomy.
Similar content being viewed by others
References
Wolf AS, Richards WG, Jaklitsch MT, et al. Lobectomy versus sublobar resection for small (≤2 cm) non-small cell lung cancers. Ann Thorac Surg. 2011;92:1819–23; discussion 1824–1825.
Altorki NK, Wang X, Wigle D, et al. Perioperative mortality and morbidity after sublobar versus lobar resection for early-stage non-small cell lung cancer: post-hoc analysis of an international, randomised, phase 3 trial (calgb/alliance 140503). Lancet Respir Med. 2018;6:915–24.
Nakamura K, Saji H, Nakajima R, et al. A phase III randomized trial of lobectomy versus limited resection for small-sized peripheral non-small cell lung cancer (jcog0802/wjog4607l). Jpn J Clin Oncol. 2010;40:271–4.
Suzuki K, Saji H, Aokage K, et al. Comparison of pulmonary segmentectomy and lobectomy: safety results of a randomized trial. J Thorac Cardiovasc Surg. 2019;158:895–907.
Dai C, Shen J, Ren Y, et al. Choice of surgical procedure for patients with non-small-cell lung cancer ≤1 cm or >1 to 2 cm among lobectomy, segmentectomy, and wedge resection: a population-based study. J Clin Oncol. 2016;34:3175–82.
Zhang C, He Z, Cheng J, Cao J, Hu J. Surgical outcomes of lobectomy versus limited resection for clinical stage C ground-glass opacity lung adenocarcinoma 2 centimeters or smaller. Clin Lung Cancer. 2020;22:e160–8.
Saji H, Okada M, Tsuboi M, et al. Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (jcog0802/wjog4607l): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial. Lancet. 2022;399:1607–17.
Eguchi T, Sato T, Shimizu K. Technical advances in segmentectomy for lung cancer: a minimally invasive strategy for deep, small, and impalpable tumors. Cancers Basel. 2021;13:3137.
Nakamoto K, Omori K, Nezu K, Lung Cancer Project Group of West-Seto Inland Sea J. Superselective segmentectomy for deep and small pulmonary nodules under the guidance of three-dimensional reconstructed computed tomographic angiography. Ann Thorac Surg. 2010;89:877–83.
Takamori S, Oizumi H, Suzuki J, Suzuki K, Kabasawa T. Video-assisted thoracoscopic segmentectomy for deep and peripheral small lung cancer. Thorac Cardiovasc Surg. 2021;70:233–8.
Sato M, Kobayashi M, Sakamoto J, et al. The role of virtual-assisted lung mapping 2.0 combining microcoils and dye marks in deep lung resection. J Thorac Cardiovasc Surg. 2021;164:243–51.
Wu W, He Z, Xu J, et al. Anatomical pulmonary sublobar resection based on subsegment. Ann Thorac Surg. 2021;111:e447–50.
Wu WB, Xu XF, Wen W, et al. Three-dimensional computed tomography bronchography and angiography in the preoperative evaluation of thoracoscopic segmentectomy and subsegmentectomy. J Thorac Dis. 2016;8(Suppl 9):S710–5.
Yao F, Wu W, Zhu Q, Zhai R, Xu X, Chen L. Thoracoscopic pulmonary segmentectomy with collateral ventilation method. Ann Thorac Surg. 2021;112:1814–23.
Wu WB, Xia Y, Pan XL, et al. Three-dimensional navigation-guided thoracoscopic combined subsegmentectomy for intersegmental pulmonary nodules. Thorac Cancer. 2019;10:41–6.
Tsubokawa N, Tsutani Y, Miyata Y, et al. Segmentectomy versus lobectomy for radiologically pure solid clinical t1a-bn0m0 lung cancer. World J Surg. 2018;42:2493–501.
Cao J, Yuan P, Wang Y, et al. Survival rates after lobectomy, segmentectomy, and wedge resection for non-small cell lung cancer. Ann Thorac Surg. 2018;105:1483–91.
Onaitis MW, Furnary AP, Kosinski AS, et al. Equivalent survival between lobectomy and segmentectomy for clinical stage ia lung cancer. Ann Thorac Surg. 2020;110:1882–91.
Tane S, Kitamura Y, Kimura K, et al. Segmentectomy versus lobectomy for inner-located small-sized early non-small cell lung cancer. Interact Cardiovasc Thorac Surg. 2022;35:ivac218.
Tsutani Y, Miyata Y, Nakayama H, et al. Segmentectomy for clinical stage Ia lung adenocarcinoma showing solid dominance on radiology. Eur J Cardiothorac Surg. 2014;46:637–42.
Handa Y, Tsutani Y, Mimae T, et al. Oncologic outcomes of complex segmentectomy: a multicenter propensity score-matched analysis. Ann Thorac Surg. 2021;111:1044–51.
Kagimoto A, Tsutani Y, Mimae T, Miyata Y, Okada M. Segmentectomy versus lobectomy for solid predominant cn0 lung cancer: analysis using visual evaluation of positron emission tomography. Eur J Cardiothorac Surg. 2022;61:279–86.
Tane S, Kimura K, Shimizu N, et al. Segmentectomy for inner location small-sized non-small cell lung cancer: is it feasible? Ann Thorac Surg. 2021;114:1918–24.
Acknowledgement
The authors thank all the study participants, research staff, and students who participated in this study. The study was supported by the National Natural Science Foundation of China (82203296 & 81972175) and the Key Project of Jiangsu Commission of Health (ZD2022055).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Disclosure
There are no conflicts of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Right S2b+S3a combined subsegmentectomy by video-assisted thoracoscopic surgery (VATS). (MP4 121971 kb)
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Li, Z., Xu, W., Wang, J. et al. Three-Dimensional Guided Cone-Shaped Segmentectomy Versus Lobectomy for Small-sized Non-Small Cell Lung Cancer in the Middle Third of the Lung Field. Ann Surg Oncol 30, 6684–6692 (2023). https://doi.org/10.1245/s10434-023-13772-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-023-13772-1